IP Library Granted Patent US 10,463,704
Granted Patent B2
US 10,463,704 · App. 15/034,492 · Granted Nov 5, 2019

Composition comprising

Inventor: Stephen Patrick O'Hara (York, GB)
Assignee: OPTIBIOTIX LIMITED
A61K35/747A23L33/135C12N1/20A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,463,704
App. No.
15/034,492
Granted
Nov 5, 2019
Kind
B2
Abstract

The present invention relates to strain of Lactobacilli and compositions containing the strain for use in modifying the absorption of cholesterol in an individual or the treatment of heart disease, diabetes or obesity.

Claims (16)

1. A method of treating an individual with elevated cholesterol serum levels by administering a composition having an effective amount of Lactobacillus plantarum 2830 deposited at the United Kingdom National Collection of Type Cultures under ECGC 13110402.

2. The method of claim 1 , wherein the strain is administered in an amount in the range of 10 5 cfu/g to 10 12 cfu/g.

3. The method of claim 1 , wherein the composition is encapsulated.

4. The method of claim 1 , wherein the strain is mixed with a prebiotic composition.

5. The method of claim 4 , wherein the prebiotic comprises a prebiotic specific for the growth of the strain.

6. The method of claim 1 , wherein the composition is in the form of a food stuff.

7. The method of claim 1 , wherein the composition is in the form of a dietary supplement.

8. A composition comprising at least one of the strains selected from Lactobacillus plantarum 2828 deposited at the United Kingdom National Collection of Type Cultures under ECGC 13110403; Lactobacillus plantarum 2830 deposited at the United Kingdom National Collection of Type Cultures under ECGC 13110402; and Lactobacillus plantarum 2691 deposited at the United Kingdom National Collection of Type Cultures under ECGC 13110401; for use in the modification of the absorption of cholesterol or for use in the treatment of high cholesterol, heart disease, diabetes, or obesity.

9. The composition of claim 8 , wherein the composition further comprises the strain Lactobacillus acidophilus ATCC 43121.

10. The composition of claim 8 , wherein the composition comprises two or more strains selected from Lactobacillus plantarum 2828 deposited at the United Kingdom National Collection of Type Cultures under ECGC 13110403; Lactobacillus plantarum 2830 deposited at the United Kingdom National Collection of Type Cultures under ECGC 13110402; Lactobacillus plantarum 2691 deposited at the United Kingdom National Collection of Type Cultures under ECGC 13110401; and Lactobacillus acidophilus ATCC 43121.

11. The composition of claim 8 , wherein the strain or strains is/are in an amount in the range of 10 5 cfu/g to 10 12 cfu/g.

12. The composition of claim 8 , wherein the composition is encapsulated.

13. The composition of claim 8 , wherein the strain or strains is/are mixed with a prebiotic composition.

14. The composition of claim 13 , wherein the prebiotic comprises a prebiotic specific for the growth of the strain or strains.

15. The composition of claim 8 , wherein the composition is in the form of a food stuff.

16. The composition of claim 8 , wherein the composition is in the form of a dietary supplement.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 22, 2021
From: OPTIBIOTIX LIMITED
To: OPTIBIOTIX HEALTH PLC
Reel/Frame 058458/0321 →
CONFIRMATORY LICENSE Recorded Dec 22, 2021
From: OPTIBIOTIX HEALTH PLC
To: PROBIOTIX HEALTH LIMITED
Reel/Frame 058458/0472 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2019
From: O'HARA, STEPHEN PATRICK
To: OPTIBIOTIX LIMITED
Reel/Frame 050265/0805 →
Priority Claims (1)
GB 1319540.9 · Nov 5, 2013 · national
Continuity (1)
Related Publication 20160287645A1 · Oct 6, 2016
Cited By (1)
US 12,673,076